Axa Framlington has hired Andy Smith to run its Biotech Fund alongside with Deane Donnigan, Gemma G...
Axa Framlington has hired Andy Smith to run its Biotech Fund alongside with Deane Donnigan, Gemma Game and Antony Milford. He will join on 3 April and report directly to Axa Framlington CEO, Robert Kyprianou. Smith comes from SV Life Sciences where he managed the International Biotechnology Trust and has 30 years experience in the global healthcare industry.
To continue reading this article...
Join Investment Week for free
Signup and gain exclusive members-only insights - all free of charge!
- Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
- Get ahead of regulatory and technological changes affecting fund management
- Important and breaking news stories selected by the editors delivered straight to your inbox each day
- Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
- Be the first to hear about our extensive events schedule and awards programmes
